Ocular Hypertension Treatment Market to Make Great Impact in Near Future by 2030

Ocular Hypertension Treatment: Introduction

Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up.

An injury to the eye, certain diseases, and some medications could raise eye pressure

Read Report Overview - https://www.transparencymarketresearch.com/ocular-hypertension-treatment-market.html

Key Drivers of Global Ocular Hypertension Treatment Market

Increase in incidence of ophthalmic diseases and constant rise in the geriatric population that is highly susceptible to eye disorders drive the global ocular hypertension treatment market

Eye-related disorders have emerged as potential threats to the populations in all middle-income and industrialized countries. Leading causes of vision impairment include uncorrected refractive errors, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy, corneal opacity, and trachoma. Among these, cataract and uncorrected refractive errors are the most frequent and leading causes of blindness across the world.

According to the World Health Organization, an estimated 1.3 billion people were living with some form of vision impairment globally in 2018. According to CDC report, nearly 20.5 million (17.2%) people in the U.S. aged 40 years and above have cataract in one or both eyes, and 6.1 million (5.1%) have had their lens removed operatively. The total number of people who have cataract is projected to increase to 30.1 million by 2020.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81104

Rise in awareness among people and increase in government initiatives for vision care management are anticipated to drive the global ocular hypertension treatment market

Intraocular Hypertension Segment to Dominate Global Market

In terms of type, the global ocular hypertension treatment market can be bifurcated into intraocular hypertension and glaucoma

The intraocular hypertension segment is expected to dominate the global market during the forecast period due to high prevalence of intraocular hypertension

Get COVID-19 Analysis on Ocular Hypertension Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81104

Oral Segment to Lead Global Market

Based on route of administration, the global ocular hypertension treatment market can be classified into oral, parenteral, and others

The oral segment is likely to dominate the global market during the forecast period due to safety, good patient compliance, ease of ingestion, and no pain

Hospitals to be Highly Lucrative Segment

In terms of end-user, the global ocular hypertension treatment market can be categorized into hospitals, specialty clinics, and others

The hospitals segment is projected to account for major share of the global ocular hypertension treatment market by 2030 due to a large number of patients treated in hospitals for ocular hypertension treatment

North America to Offer Significant Opportunities in Ocular Hypertension Treatment Market

In terms of region, the global ocular hypertension treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America dominated the global ocular hypertension treatment market in 2019. Availability of patient assistance programs and increase in research & development activities for the development of novel therapies are anticipated to drive the ocular hypertension treatment market in North America.

Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=81104

Key Players Operating in Global Ocular Hypertension Treatment Market

The global ocular hypertension treatment market is highly fragmented, with the presence of international and local players. Key players operating in the global ocular hypertension treatment market are:

Aerie Pharmaceuticals, Inc.

Allergan plc

Angelini Group

Chong Kun Dang Pharmaceutical Corp.

Laboratorios SALVAT SA

Laboratorios Sophia SA de CV

Lee's Pharmaceutical Holdings Ltd.

Neurim Pharmaceuticals Ltd.

NicOx SA

Novartis AG

More Trending Reports by Transparency Market Research -

Durable Medical Equipment (DME) Market: https://www.prnewswire.co.uk/news-releases/manufacturers-of-durable-medical-equipment-dme-market-bank-on-opportunities-from-healthcare-programs-in-home-settings-valuation-to-surpass-us-261-0-bn-by-2027-says-tmr-880763685.html

Electrophysiology Devices Market: https://www.prnewswire.com/news-releases/increasing-prevalence-of-atrial-fibrillation-to-underscore-electrophysiology-devices-market-growth-tmr-study-301106801.html

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

This release was published on openPR.